INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2014

A case report describes thyrotoxic periodic paralysis and severe hypokalemia linked to a weight-loss nutraceutical containing triiodothyronine (T3).

A 24-year-old healthy manual laborer developed quadriparesis during rest following heavy exertion and carbohydrate intake. He presented with severe hypokalemia (potassium level 1.9 mmole/L) without evidence of renal or gastrointestinal potassium wasting. Laboratory studies confirmed factitious T3 toxicosis after he reported consuming nutraceuticals containing T3 for 1 month for weight loss. Correcting the hypokalemia reversed the paralysis, and avoiding further T3 intake prevented recurrence.

Shows an association, not proof of cause and effect.

Study type
Case report
Who was studied
A 24-year-old male manual laborer
What was measured
Quadriparesis, hypokalemia, and thyrotoxic periodic paralysis following nutraceutical intake

THE PAPER

I lost weight, but I became weak and cannot walk--a case of nutraceutical (T3)-induced thyrotoxic periodic paralysis.

Panikkath R, Nugent K. Am J Ther, 2014.

PubMed 23567793 ↗DOI 10.1097/mjt.0b013e318288a460 ↗

Nutrients & adequacyWeight & appetiteFood safety & contaminantsOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.